Your Messages Inbox
Your Article Summary
See Latest ArticlesSuperior efficacy-dose ratio for Lantus over detemir
Sanofi-aventis, 10/01/09
Sanofi–aventis announced results of a head–to–head study providing further evidence on the efficacy of once–daily, 24–hour basal insulin Lantus compared to twice–daily insulin detemir. The study was presented during the 45th Annual Meeting of the European Association for the Study of Diabetes in Vienna.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09
User Groups Prove Helpful
HealthDataManagement, 11/03/09
Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09
Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09
Article Search
Sponsor